Munafa Stock Market Course + Intraday & FNO calls 
TAK NEWS why is Takeda Pharmaceutical Company Limited price falling or rising
TAK NEWS reasons for why stock price of Takeda Pharmaceutical Company Limited is falling or rising
TAK Takeda Pharmaceutical is falling or rising technical reasons
Technical analysis forecast of Takeda Pharmaceutical Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Takeda Pharmaceutical TAK at this time. Stock is rising and might rise more.
It appears as if Takeda Pharmaceutical TAK gave a large move recently.
Stock of Takeda Pharmaceutical (TAK) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
Although my analysis for Takeda Pharmaceutical is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 14.8, for a target of 14.5 or 14.38
TAK Takeda Pharmaceutical is falling or rising NEWS fundamental reasons
Taxation of Equity Arbitrage Fund is perfect example of Aacharya’s advice, says Nilesh Shah of Kotak Mutual Fund Nilesh Shah of Kotak Mutual Fund says equity arbitrage fund taxation mirrors Chanakya’s advice of gentle taxation. Despite low-volatility returns, Kotak Equity Arbitrage Fund generated significant government revenue through STCG and transaction charges, wi - NEWS as on 2025-12-19 indiatimes.com
Kotak Mutual Fund: SBI, Eternal, and RIL among top 10 stock holdings in November Kotak Mutual Fund managed assets worth Rs 5.94 lakh crore as of November 2025, with major allocations across banking, telecom and large-cap stocks. HDFC Bank, ICICI Bank and SBI remained top holdings, while selective increases were seen in Bharti Airtel, A - NEWS as on 2025-12-18 indiatimes.com
Kotak upgrades Vedanta stock to Buy, raises target price after NCLT nod for demerger Kotak Institutional Equities upgraded Vedanta to Buy after NCLT approved its demerger, raising the target price to Rs 650 and citing strong commodity prices, improving balance-sheet outlook and robust earnings growth potential through FY28 - NEWS as on 2025-12-17 indiatimes.com
Kaynes Tech share selloff: Kotak vs JPMorgan, Morgan Stanley, Nomura. Here’s what brokerages are saying Kaynes Technology’s steep decline has sparked intense scrutiny after accounting inconsistencies flagged by Kotak raised concerns over disclosures and smart-metre dependence. While this triggered the sell-off, most brokerages argue fundamentals remain intac - NEWS as on 2025-12-11 indiatimes.com
Nifty can cross 32K in 2026 bull case scenario: Kotak Securities In a recent note, domestic brokerage firm Kotak Securities has projected a bull case target of 32,032 for the Nifty 50 index by December 2026, suggesting meaningful upside potential from current levels, highlighting a preference for BFSI, and IT sectors, a - NEWS as on 2025-12-10 indiatimes.com
Credit provided by capital markets will overtake bank credit: Kotak Mahindra AMC chief Nilesh Shah Mutual fund credit is set to surpass bank credit. Nilesh Shah of Kotak Mahindra AMC predicts this shift. He urges Indians to invest wisely, moving away from unproductive habits. Radhika Gupta of Edelweiss Mutual Fund suggests incentives for early investmen - NEWS as on 2025-12-09 indiatimes.com
Kaynes Tech shares fall 6% as Kotak flags issues Kaynes Technology shares fell 6% after Kotak Institutional Equities highlighted discrepancies in inter-company transaction disclosures between the parent and its subsidiaries. The brokerage noted significant unrecorded transactions and receivables, alongsi - NEWS as on 2025-12-05 indiatimes.com
More announcements and NEWS
TAK Takeda Pharmaceutical Company Limited current price & indicator signals
Recent prices of TAK Takeda Pharmaceutical Company Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 18 Thu Dec 2025 | 14.83 | 14.66 to 14.90 | 2.49% | 2.43 times |
| 17 Wed Dec 2025 | 14.47 | 14.43 to 14.54 | -0.41% | 0.85 times |
| 16 Tue Dec 2025 | 14.53 | 14.48 to 14.66 | -0.55% | 1.47 times |
| 15 Mon Dec 2025 | 14.61 | 14.40 to 14.61 | 1.95% | 1.26 times |
| 12 Fri Dec 2025 | 14.33 | 14.20 to 14.35 | -0.42% | 1.01 times |
| 11 Thu Dec 2025 | 14.39 | 14.37 to 14.53 | 0.14% | 0.97 times |
| 10 Wed Dec 2025 | 14.37 | 14.27 to 14.40 | 0.77% | 0.97 times |
| 09 Tue Dec 2025 | 14.26 | 14.25 to 14.41 | 0.28% | 0.8 times |
| 08 Mon Dec 2025 | 14.22 | 14.17 to 14.27 | 0.28% | 0.89 times |
| 05 Fri Dec 2025 | 14.18 | 14.16 to 14.33 | -0.7% | 0.89 times |
| 04 Thu Dec 2025 | 14.28 | 14.26 to 14.42 | -0.21% | 0.89 times |
| 03 Wed Dec 2025 | 14.31 | 14.28 to 14.40 | 0.14% | 1.01 times |
Videos related to: TAK NEWS why is Takeda Pharmaceutical Company Limited price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance
